- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Danbury Hospital Danbury, Connecticut, United States
- ProHealth Care Inc Waukesha, Wisconsin, United States
Clinical trial condition
Platinum-sensitive Ovarian Cancer
Explore clinical trials studying Platinum-sensitive Ovarian Cancer. Study availability and eligibility vary by location and protocol.
8 public trials
4 recruiting studies
Platinum-sensitive Ovarian Cancer trial results
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- Mt. Sinai Comprehensive Cancer Center Miami, Florida, United States
- Sarasota Memorial Health Care System Sarasota, Florida, United States
- Miami Valley Hospital South Centerville, Ohio, United States
- Zangmeister Cancer Center Columbus, Ohio, United States
NCT07024784
- Conditions
- Adnexal Diseases, Fallopian Tube Cancer, Fallopian Tube Diseases, +13 more
- Locations
-
- Holy Name Medical Center /ID# 279017 Teaneck, New Jersey, United States
- University of Cincinnati Medical Center. /ID# 278925 Cincinnati, Ohio, United States
- OU Health - Stephenson Cancer Center /ID# 277656 Oklahoma City, Oklahoma, United States
- Providence Portland Medical Center /ID# 277727 Portland, Oregon, United States
Recruiting
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
NCT06686030
- Conditions
- Platinum-sensitive Ovarian Cancer
- Locations
-
- Union Hospital Tongji Medical College Huazhong University of Science And Technology Wuhan, China
Not Yet Recruiting
Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
NCT07454018
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
Not specified
NCT04457089
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Cedars Sinai Medical Center Los Angeles, California, United States
Completed
Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
NCT05002868
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
- Locations
-
- Multiscan s.r.o. Hořovice, Czechia
- SP ZOZ University Hospital in Krakow Oncology Clinic, 50 Kopernika Street Krakow, Poland
- Klinika Onkologii ICZMP Lodz, Poland
- Pratia Poznań Medical Center Poznan, Poland
Active, Not Recruiting
OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC
NCT04713514
- Conditions
- Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +18 more
- Locations
-
- UZ Leuven Leuven, Belgium
- Centre Hospitalier de l'Ardenne Vivalia Libramont, Belgium
- Centre Hospitalier Universitaire de Liège Liège, Belgium
- ICO Paul Papin Angers, France